Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST-Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design

Heerajnarain Bulluck, Georg M. Fröhlich, Shah Mohdnazri, Reto A. Gamma, John R. Davies, Gerald J. Clesham, Jeremy W. Sayer, Rajesh K. Aggarwal, Kare H. Tang, Paul A. Kelly, Rohan Jagathesan, Alamgir Kabir, Nicholas M. Robinson, Alex Sirker, Anthony Mathur, Daniel J. Blackman, Cono Ariti, Arvindra Krishnamurthy, Steven K. White, Pascal Meier, James C. Moon, John P. Greenwood, Derek J. Hausenloy
  • Clinical Cardiology, May 2015, Wiley
  • DOI: 10.1002/clc.22401
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1002/clc.22401

The following have contributed to this page: Heeraj Bulluck